[Naprosyn, a new nonsteroid antirheumatic agent with a long biological half-life]

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026

The brain angiotensin converting enzyme 2 and angiotensin-(1-7) as potential therapeutic targets for the central nervous system diseases.

Pharmacology & therapeutics·2026

Alterations in glymphatic system-related MRI markers in patients with primary restless legs syndrome and association with disease severity.

Sleep medicine·2026

Plasma NET-associated readouts and a multidomain neuroimmune injury axis after experimental subarachnoid hemorrhage: response to dual-pathway modulation.

Journal of neuroimmunology·2026

Related Experiment Videos

[Naprosyn, a new nonsteroid antirheumatic agent with a long biological half-life]

Related Concept Videos

Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry.

IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro.

Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases.

Circulating miRNAs in hand osteoarthritis.

A decrease in serum 1,25(OH)2D after elective hip replacement and during bone healing is associated with changes in serum iron and plasma FGF23.

Circulating miR-145 as a marker of therapeutic response to anti-TNF therapy in patients with ankylosing spondylitis.

Use of High-Flow Nasal Cannula in Amyotrophic Lateral Sclerosis Patients Intolerant to Non-Invasive Ventilation: A Case Series.

A potential therapeutic role of unilateral anterior thalamic deep brain stimulation in epileptic spasms: A case report.

Gastric amyloid pathology and mucosal denervation in ATTRv amyloidosis: insights from patients, mice, and gut microenvironment profiles.

The brain angiotensin converting enzyme 2 and angiotensin-(1-7) as potential therapeutic targets for the central nervous system diseases.

Alterations in glymphatic system-related MRI markers in patients with primary restless legs syndrome and association with disease severity.

Plasma NET-associated readouts and a multidomain neuroimmune injury axis after experimental subarachnoid hemorrhage: response to dual-pathway modulation.

Related Experiment Videos

[Naprosyn, a new nonsteroid antirheumatic agent with a long biological half-life]

Related Concept Videos

Related Articles